Cite
HARVARD Citation
Baverel, P. et al. (2018). Population Pharmacokinetics of Durvalumab in Cancer Patients and Association With Longitudinal Biomarkers of Disease Status. Clinical pharmacology & therapeutics. 103 (4), pp. 631-642. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Baverel, P. et al. (2018). Population Pharmacokinetics of Durvalumab in Cancer Patients and Association With Longitudinal Biomarkers of Disease Status. Clinical pharmacology & therapeutics. 103 (4), pp. 631-642. [Online].